Improving metastatic bone pain management with ibandronate in patients with breast cancer

被引：0
|
作者：
Body, JJ
Bergstrom, B
机构：
[1] Free Univ Brussels, Brussels, Belgium
[2] Hoffmann La Roche Inc, Nutley, NJ 07110 USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2004年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S134 / S134
页数：1
相关论文
共 50 条
  • [31] CRYOHYPOPHYSECTOMY FOR BONE PAIN OF METASTATIC BREAST-CANCER
    GYE, RS
    STANWORTH, PA
    STEWART, JA
    ADAMS, CBT
    PAIN, 1979, 6 (02) : 201 - 206
  • [32] Pain in Metastatic Breast Cancer: Complementary Pain Management Therapies
    Fitzpatrick, Molly
    NURSING RESEARCH, 2020, 69 (03) : E160 - E160
  • [33] Reducing skeletal complications and bone pain with intravenous ibandronate for metastatic bone disease
    Body, JJ
    EJC SUPPLEMENTS, 2004, 2 (05): : 5 - 8
  • [34] Oral ibandronate improves bone pain and preserves quality of life in patients with skeletal metastases due to breast cancer
    Body, JJ
    Diel, IJ
    Bell, R
    Pecherstorfer, M
    Lichinitser, MR
    Lazarev, AF
    Tripathy, D
    Bergström, B
    PAIN, 2004, 111 (03) : 306 - 312
  • [35] Ibandronate in clinical practice: renal safety and tolerability in patients with metastatic breast cancer
    Diel, I. J.
    Bergner, R.
    Seraphin, J.
    EJC SUPPLEMENTS, 2009, 7 (02): : 281 - 281
  • [36] Breast Cryoablation in Patients with Bone Metastatic Breast Cancer
    Pusceddu, Claudio
    Sotgia, Barbara
    Amucano, Giovanni
    Fele, Rosa Maria
    Pilleri, Sara
    Meloni, Giovanni Battista
    Melis, Luca
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2014, 25 (08) : 1225 - 1232
  • [37] Loading Dose Ibandronate Versus Standard Oral Ibandronate in Patients With Bone Metastases From Breast Cancer
    Macpherson, Iain R.
    Bray, Caroline
    Hopkins, Carol
    Hannon, Rosemary A.
    Lewsley, Liz-Anne
    Ritchie, Diana M.
    Canney, Peter
    CLINICAL BREAST CANCER, 2015, 15 (02) : 117 - 127
  • [38] Management of patients with metastatic breast cancer
    Jurado J.C.
    Aznar P.R.
    Mata J.G.
    Martínez R.F.
    Fernández I.P.
    Gimeno T.S.
    Calvo E.G.
    Jaso L.M.
    Marqués E.P.
    Palomo A.G.
    Advances in Therapy, 2011, 28 (Suppl 6) : 50 - 65
  • [39] Ibandronate Shows Marked Pain Relief and a Favorable Renal Safety Profile - Updated Results of a Non Interventional Study in Breast Cancer Patients with Metastatic Bone Disease
    Schmidt, M.
    Hesse, T.
    Kuehnle, H.
    Lerchenmueller, C.
    Schlag, R.
    CANCER RESEARCH, 2009, 69 (24) : 573S - 573S
  • [40] Oral ibandronate and intravenous zoledronic acid in metastatic breast cancer patients:: Comparative bone turnover marker and safety data
    Body, JJ
    Lichinitser, M
    Coleman, RE
    Bergström, B
    BONE, 2006, 38 (03) : S69 - S69
12345